Increased incidence of type 2 diabetes mellitus and obesity has elevated the medical need
for new agents to treat these disease states. Resistance to the hormones insulin and leptin …

Several 'classical'protein tyrosine phosphatases are attractive therapeutic targets, including
PTP1B for obesity and Type II diabetes; SHP2 for cancer and Lyp for rheumatoid arthritis …

This study examined the influence of green financing, renewable energy, and energy
transition. Although the importance of natural resources has been discussed in the current …

The decline in environmental quality is influenced by natural resource use, which, in turn,
affects economic growth. The Sustainable Development Goal (SDG) has helped bring …

Green financing development mediated the interaction between industrial structure changes
and renewable energy growth in China from 2000 to 2021. The research examines whether …

The global epidemic of obesity and type-2 diabetes mellitus (T2DM) has highlighted the
need for new therapeutic approaches. The association of insulin resistance with these …

Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of the leptin and insulin
signaling pathways. The important roles of PTP1B related to obesity and diabetes were …

Protein tyrosine phosphatase 1B (PTP1B) is an enzyme that downregulates the insulin
receptor. Inhibition of PTP1B is expected to improve insulin action, and the design of small …

Insulin resistance is a key pathological feature of type 2 diabetes and is characterized by
defects in signaling by the insulin receptor (IR) protein tyrosine kinase. The inhibition of …

Vanadium is omnipresent in trace amounts in the environment, in food and also in the
human body, where it might serve as a regulator for phosphate-dependent proteins …